Cholangiocarcinoma is a type of cancer that arises from the cells of bile ducts. It is also known as bile duct cancer and is a rare cancer that can affect both the intrahepatic (within the liver) and extrahepatic (outside the liver) bile ducts. Bile ducts are involved in the production and transport of bile, a yellowish-green substance composed of bile salts, cholesterol, and other components that help the body digest fat. Cholangiocarcinoma can be classified as either primary or secondary. Primary cholangiocarcinoma originates from the bile ducts, while secondary cholangiocarcinoma is caused by cancer that has spread to the bile ducts from other parts of the body. The risk factors for cholangiocarcinoma include chronic biliary diseases such as primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Other risk factors include smoking, excessive alcohol intake, and certain genetic disorders. There may also be a link between cholangiocarcinoma and certain infections or toxins.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy